On September 7, 2020 Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, reported that CEO, Gérard Soula, will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, held virtually this year, September 14-16, 2020 (Press release, Adocia, SEP 7, 2020, https://www.adocia.com/september-15th-adocia-to-present-at-h-c-wainwright-global-investment-conference/ [SID1234565004]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation details:
Presenter: Gérard Soula, CEO
Presentation Day: September 15, 2020
Time: 1:00 PM (EDT) / 7:00 PM (CEST)
Link to the online presentation (live and archived for 90 days)